A new four-in-one rapid home test kit detects COVID-19, influenza A, influenza B, and RSV in just 15 minutes, offering an alternative to urgent care visits during the winter respiratory illness season, the NY Post reported.
As the holiday season approaches, large-scale family gatherings and seasonal travel bring increased exposure to circulating pathogens. Taking an at-home antigen test provides a firm diagnosis that can guide rest, nutritional intake, and isolation decisions before symptoms worsen or spread to vulnerable individuals, according to the NY Post.
The iHealth four-in-one rapid test is cleared by the U.S. Food and Drug Administration under a 510(k) pathway, meaning it has demonstrated substantial equivalence to a legally marketed predicate device. The over-the-counter kit requires no prescription and is authorized for self-testing by individuals aged 14 and older, while adults can administer the nasal swab collection to children as young as six months old.
The diagnostic mechanism relies on lateral flow immunoassay technology. When a nasal swab sample is mixed with the extraction buffer and applied to the test cassette, viral proteins bind to specific antibodies conjugated to colored nanoparticles, producing distinct visual lines for each target pathogen within a quarter of an hour.
Visiting a traditional medical clinic or urgent care center for a mild respiratory infection often introduces secondary infection vectors. Patients frequently sit in enclosed waiting rooms alongside individuals carrying different contagious viruses, running the risk of contracting a secondary illness despite testing negative for their initial complaint, the NY Post reported.
Utilizing a multi-pathogen test at home eliminates travel time and minimizes community transmission within healthcare facilities. The compact design of the packaging also allows individuals to pack the diagnostic kits easily for use while traveling during the holidays.
| Test Feature | Specification |
|---|---|
| Target Pathogens | COVID-19, Influenza A, Influenza B, RSV |
| Time to Result | 15 Minutes |
| Regulatory Status | FDA 510(k) Cleared |
A negative antigen test result does not definitively rule out viral infection, particularly during the early stages of illness when viral load may be below the limit of detection. Official testing guidelines recommend closely following package instructions, obtaining a sufficient nasal sample, and swabbing at least twice over three days with a minimum of 48 hours between tests.
Individuals experiencing severe symptoms such as acute shortness of breath, persistent chest pain, confusion, or inability to maintain hydration should bypass home testing and seek immediate medical evaluation at an emergency department or urgent care facility.
